Patterns of Physical Activity Progression in Patients With COPD.

Actividad física Análisis de conglomerados COPD Cluster analysis Determinantes Determinants EPOC Patrones de progresión Patterns of progression Physical activity

Journal

Archivos de bronconeumologia
ISSN: 2173-5751
Titre abrégé: Arch Bronconeumol (Engl Ed)
Pays: Spain
ID NLM: 101777538

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 17 06 2020
revised: 24 07 2020
accepted: 06 08 2020
pubmed: 13 10 2020
medline: 25 6 2021
entrez: 12 10 2020
Statut: ppublish

Résumé

Although mean physical activity in COPD patients declines by 400-500steps/day annually, it is unknown whether the natural progression is the same for all patients. We aimed to identify distinct physical activity progression patterns using a hypothesis-free approach and to assess their determinants. We pooled data from two cohorts (usual care arm of Urban Training [NCT01897298] and PROactive initial validation [NCT01388218] studies) measuring physical activity at baseline and 12 months (Dynaport MoveMonitor). We identified clusters (patterns) of physical activity progression (based on levels and changes of steps/day) using k-means, and compared baseline sociodemographic, interpersonal, environmental, clinical and psychological characteristics across patterns. In 291 COPD patients (mean±SD 68±8 years, 81% male, FEV The natural progression in physical activity over time in COPD patients is heterogeneous. While Inactive patients relate to worse scores for clinical COPD characteristics, Active Improvers and Decliners cannot be predicted at baseline.

Identifiants

pubmed: 33041107
pii: S0300-2896(20)30280-5
doi: 10.1016/j.arbres.2020.08.001
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

214-223

Investigateurs

Ane Arbillaga-Etxarri (A)
Marta Benet (M)
Anna Delgado (A)
Judith Garcia-Aymerich (J)
Elena Gimeno-Santos (E)
Jaume Torrent-Pallicer (J)
Jordi Vilaró (J)
Anael Barberan-Garcia (A)
Robert Rodriguez-Roisín (R)
Eva Balcells (E)
Diego A Rodríguez Chiaradía (DAR)
Alicia Marín (A)
Pilar Ortega (P)
Nuria Celorrio (N)
Mónica Monteagudo (M)
Nuria Montellà (N)
Laura Muñoz (L)
Pere Toran (P)
Pere Simonet (P)
Carme Jané (C)
Carlos Martín-Cantera (C)
Eulàlia Borrell (E)
Pere Vall-Casas (P)
Nathalie Ivanoff (N)
Niklas Karlsson (N)
Solange Corriol-Rohou (S)
Ian Jarrod (I)
Damijen Erzen (D)
Caterina Brindicci (C)
Tim Higenbottam (T)
Mario Scuri (M)
Paul McBride (P)
Nadia Kamel (N)
Margaret Tabberer (M)
Thierry Troosters (T)
Fabienne Dobbels (F)
Judith Garcia-Aymerich (J)
Pim de Boer (P)
Karoly Kulich (K)
Alastair Glendenning (A)
Katja Rudell (K)
Frederick J Wilson (FJ)
Michael I Polkey (MI)
Nick S Hopkinson (NS)
Ioannis Vogiatzis (I)
Enkeleida Nikai (E)
Thys van der Molen (T)
Corina De Jong (C)
Roberto A Rabinovich (RA)
Bill MacNee (B)
Milo A Puhan (MA)
Anja Frei (A)

Informations de copyright

Copyright © 2020 SEPAR. Publicado por Elsevier España, S.L.U. All rights reserved.

Auteurs

Maria Koreny (M)

ISGlobal, Barcelona, Spain; Pompeu Fabra University (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Heleen Demeyer (H)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgium; Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.

Marta Benet (M)

ISGlobal, Barcelona, Spain; Pompeu Fabra University (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.

Ane Arbillaga-Etxarri (A)

Physical Activity and Sports Sciences, Faculty of Psychology and Education, University of Deusto, Donostia-San Sebastián, Spain.

Eva Balcells (E)

Pompeu Fabra University (UPF), Barcelona, Spain; CIBER Enfermedades Respiratorias (CIBERES), Madrid, Spain; Pneumology Department, Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Hospital del Mar, Barcelona, Spain.

Anael Barberan-Garcia (A)

University of Barcelona, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), CIBER Enfermedades Respiratorias (CIBERES), Hospital Clínic, Barcelona, Spain.

Elena Gimeno-Santos (E)

University of Barcelona, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), CIBER Enfermedades Respiratorias (CIBERES), Hospital Clínic, Barcelona, Spain.

Nicholas S Hopkinson (NS)

National Heart and Lung Institute, Imperial College, Royal Brompton Hospital Campus, London UK.

Corina De Jong (C)

Department of General Practice, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands; Groningen Research Institute for Asthma and COPD (GRIAC), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Niklas Karlsson (N)

Patient Centered Science, BioPharmaceuticals, AstraZeneca R&D, Gothenburg, Sweden.

Zafeiris Louvaris (Z)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; First Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, Greece.

Michael I Polkey (MI)

National Heart and Lung Institute, Imperial College, Royal Brompton Hospital Campus, London UK.

Milo A Puhan (MA)

Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

Roberto A Rabinovich (RA)

ELEGI Colt Laboratory, Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK.

Robert Rodríguez-Roisin (R)

University of Barcelona, Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), CIBER Enfermedades Respiratorias (CIBERES), Hospital Clínic, Barcelona, Spain.

Pere Vall-Casas (P)

Universitat Internacional de Catalunya (UIC), Barcelona, Spain.

Ioannis Vogiatzis (I)

First Department of Respiratory Medicine, National and Kapodistrian University of Athens, Athens, Greece; Department of Sport, Exercise and Rehabilitation, Northumbria University Newcastle, Newcastle UK.

Thierry Troosters (T)

Department of Rehabilitation Sciences, KU Leuven - University of Leuven, Leuven, Belgium; Department of Respiratory Diseases, University Hospitals KU Leuven, Leuven, Belgium.

Judith Garcia-Aymerich (J)

ISGlobal, Barcelona, Spain; Pompeu Fabra University (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain. Electronic address: judith.garcia@isglobal.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH